Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype.

Neurology - 29 Nov 2011

Matthews E, Portaro S, Ke Q, Sud R, Haworth A, Davis M B, Griggs R C, Hanna M G

Abstract excerpt

OBJECTIVES: Acetazolamide has been the most commonly used treatment for hypokalemic periodic paralysis since 1968. However, its mechanism of efficacy is not fully understood, and it is not known whether therapy response relates to genotype. We undertook a clinical and genetic study to evaluate th...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Cardiac electrophysiology and arrhythmias
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Hypokalemic Periodic Paralysis

Share to Ion channel regulation and function

Share to Predictive Value of Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 22094484
DOI: 10.1212/WNL.0b013e31823a0cb6
PMCID: PMC3235354

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22094484-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype.PMID 22094484Read ↗

Hypokalemic periodic paralysis; two different genes responsible for similar clinical manifestationsSemantic proximity Read ↗

The R900S mutation in CACNA1S associated with hypokalemic periodic paralysis.Semantic proximity Read ↗

Genotype and phenotype analysis of patients with sporadic periodic paralysis.Semantic proximity Read ↗

Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis.Semantic proximity Read ↗

[Screening of genetic mutations in a Chinese pedigree affected with hypokalemic periodic paralysis].Semantic proximity Read ↗

Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis.Semantic proximity Read ↗

Mutation screening in Korean hypokalemic periodic paralysis patients: a novel SCN4A Arg672Cys mutation.Semantic proximity Read ↗

Mutation analysis of CACNA1S and SCN4A in patients with hypokalemic periodic paralysis.Semantic proximity Read ↗

The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis.Semantic proximity Read ↗

Severity of obstructive sleep apnea influences the effect of genotype on response to anti-arrhythmic drug therapy for atrial fibrillation.Semantic proximity Read ↗

Long-term effectiveness of acetazolamide on permanent weakness in hyperkalemic periodic paralysis.Semantic proximity Read ↗

Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in chinese patients with hypokalemic periodic paralysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.